For in-vitro research only · Not for human use · 18+

New prices. Permanently 30% lower.Already marked down from original prices · No code needed
← Back to all articles

CJC-1295 molecular identity and DAC terminology

October 30, 2026

CJC-1295 in molecular research

CJC-1295 is a name used in research on growth-hormone-releasing hormone analogues. The 2005 study by Jetté and colleagues identifies the compound within a series of hGRF(1–29)-albumin bioconjugates. Its title describes GRF receptor activity in a rat pituitary model. This makes the defined molecular design, not simply the short name, central to interpreting the publication.

DAC and compound identity

DAC terminology relates to the albumin-binding design associated with this analogue. An albumin bioconjugate is not interchangeable with a peptide identified only by a similar catalogue name. A molecular reference needs the sequence, chemical modifications and relevant identifiers before results from one defined analogue can be compared with another material.

The peptide label CJC-1295 (No DAC) is terminology used for catalogue variants. The label alone does not establish equivalence to the albumin-bioconjugate examined in the original CJC-1295 research. This article does not assign an unreported sequence to the labelled material or describe it as the original studied molecule.

For receptor research, keep analogue identity, assay system and experimental endpoint separate. A receptor result for an albumin-binding analogue cannot establish the same result for a different peptide solely because both descriptions include CJC-1295. The primary paper is a reference for its defined experimental material, not a catalogue-lot characterization.

References

Jetté et al. (2005): hGRF(1–29)-albumin bioconjugates and identification of CJC-1295

Materials in this catalogue are offered for in-vitro laboratory research only, not human or veterinary use. This reference does not provide dosing, preparation, storage or treatment instructions.

Check the listing identity

Read the compound name, labelled amount and any blend composition on the current product listing. An amount per vial is not a dose or a preparation protocol. Current prices and availability belong to the catalogue, not an older article.

Check a lot document, where published

A report is shown only if one has been published for that lot. Compare its identifiers with the listing and vial label. A missing report is not evidence of testing or quality.

Consult the appropriate source

For handling, consult the supplier safety data sheet and your institution's standard operating procedures. For regulatory questions, consult official TGA guidance; a research-use label does not determine legal status.

Research catalogue · Lot documents · Official guidance · Shipping details and carrier estimates · Contact

Related articles